You are here

Atorvastatin For The Reduction Of Ventricular Arrhythmias

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Aalst, , Belgium
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Arrhythmia
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Eligible subjects were male or female subjects, age >18 years, with clinically
documented coronary artery disease and life-threatening ventricular arrhythmias who
met the following criteria:

- Were scheduled for an ICD implantation or had an ICD implantation within 1 month,
according to the class I American College of Cardiology/American Heart Association
(ACC/AHA) practice guidelines for ICD therapy

OR

- Were already treated with an ICD for a class I ACC/AHA indication for more than one
month, provided they received at least one appropriate ICD intervention (shock or
antitachycardia pacing (ATP) for ventricular tachycardia or ventricular fibrillation)
during the preceding six months

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patients with ventricular arrhythmias in the acute phase of myocardial infarction
(first 48 hours).

- Patients with incessant ventricular tachycardia.

- Patients with ventricular arrhythmias without underlying coronary artery disease.

- Patients with a transient or reversible cause of ventricular arrhythmias (including
significant electrolyte disturbances or drug induced proarrhythmia).

NCT00457340
Pfizer
Completed
Atorvastatin For The Reduction Of Ventricular Arrhythmias

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now